Yahaya Ali Ahmed, Fuller Walter, Kithinji Dennis, Mazengiya Yidnekachew Degefaw, Gahimbare Laetitia, Bishikwabo-Nsarhaza Kizito
WHO Regional Office for Africa, Cité du Djoué, Brazzaville P.O. Box 06, Congo.
MedRight Consulting Ltd., Maua P.O. Box 254715149694-60600, Kenya.
Antibiotics (Basel). 2024 Oct 9;13(10):943. doi: 10.3390/antibiotics13100943.
The WHO Regional Office for Africa developed a Member States (MS)-endorsed regional strategy to fast-track the implementation of MS' national action plans (NAP) on Antimicrobial resistance (AMR). This study explored the perspectives of AMR's national focal points in MS on the implementation of the priority interventions of the regional strategy in their countries. An online survey consisting of ratings and discussions covering the implementation of the six priority interventions was conducted. Sums of the scores per priority intervention were obtained, and their percentage to the total possible scores were calculated to categorize the implementation as inadequate (0-25%), basic (26-50%), intermediate (51-75%), or advanced (76-100%). Thirty-six of the forty-seven national AMR focal points responded to the survey between 12 November 2023 and 8 January 2024. The implementations were rated as 37-62% (basic-to-intermediate), with the multisectoral coordination and collaboration committee receiving the highest overall rating (62%, 421/684), while the promotion of sustainable investment for the NAP on AMR received the least overall rating (37%, 257/700). The focal points mainly recommended awareness campaigns, capacity building, and regulations and guidelines to improve the implementation of the AMR strategy. The survey revealed a need to enhance awareness campaigns, support the establishment and functioning of AMR evaluation and monitoring systems, and build the capacity of AMR staff with cost-benefit analysis and budgeting skills. It also showed the necessity to improve awareness and conduct education on AMR, streamline evidence generation through One Health Surveillance systems, integrate initiatives to reduce hospital-acquired infections in the antimicrobial stewardship programs, and enhance regulations and guidelines to optimize the use of antimicrobials.
世界卫生组织非洲区域办事处制定了一项经成员国认可的区域战略,以加快成员国关于抗微生物药物耐药性(AMR)的国家行动计划(NAP)的实施。本研究探讨了成员国中AMR国家协调人对于在其国家实施区域战略优先干预措施的看法。开展了一项在线调查,内容包括对六项优先干预措施实施情况的评分和讨论。得出每项优先干预措施的得分总和,并计算其占总分的百分比,以将实施情况分类为不足(0-25%)、基本(26-50%)、中等(51-75%)或先进(76-100%)。47名国家AMR协调人中有36人在2023年11月12日至2024年1月8日期间回复了调查。实施情况被评为37%-62%(基本至中等),多部门协调与合作委员会获得的总体评分最高(62%,421/684),而促进AMR国家行动计划的可持续投资获得的总体评分最低(37%,257/700)。协调人主要建议开展提高认识运动、能力建设以及制定法规和指南,以改善AMR战略的实施。调查显示需要加强提高认识运动,支持AMR评估和监测系统的建立与运作,并培养具备成本效益分析和预算技能的AMR工作人员的能力。调查还表明有必要提高对AMR的认识并开展相关教育,通过“同一个健康”监测系统简化证据生成,将减少医院获得性感染的举措纳入抗菌药物管理计划,并加强法规和指南以优化抗菌药物的使用。